CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
43 hedge funds and large institutions have $21M invested in CTI BioPharma Corp. (DE) Common Stock in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
43
Holding in Top 10
–
Calls
$34K
Puts
–
Top Buyers
| 1 | +$235K | |
| 2 | +$234K | |
| 3 | +$44.4K | |
| 4 |
D.E. Shaw & Co
New York
|
+$8.49K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$8K |
Top Sellers
| 1 | -$390K | |
| 2 | -$390K | |
| 3 | -$364K | |
| 4 |
Goldman Sachs
New York
|
-$326K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$161K |